Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 143

1.

Differential Molecular Modeling Predictions of Mid and Conventional Dialysate Flows.

Leypoldt JK, Prichard S, Chertow GM, Alvarez L.

Blood Purif. 2019 Jan 30:1-8. doi: 10.1159/000495022. [Epub ahead of print]

PMID:
30699416
2.

Intradialytic kinetics of middle molecules during hemodialysis and hemodiafiltration.

Leypoldt JK, Storr M, Agar BU, Boschetti-de-Fierro A, Bernardo AA, Kirsch AH, Rosenkranz AR, Krieter DH, Krause B.

Nephrol Dial Transplant. 2018 Oct 10. doi: 10.1093/ndt/gfy304. [Epub ahead of print]

PMID:
30307514
3.

Calculating Standard Kt/V during Hemodialysis Based on Urea Mass Removed.

Leypoldt JK, Vonesh EF.

Blood Purif. 2019;47(1-3):62-68. doi: 10.1159/000493178. Epub 2018 Oct 8.

PMID:
30296780
4.

Volume of urea cleared as a therapy dosing guide for more frequent hemodialysis.

Leypoldt JK, Weinhandl ED, Collins AJ.

Hemodial Int. 2019 Jan;23(1):42-49. doi: 10.1111/hdi.12692. Epub 2018 Sep 25.

PMID:
30255600
5.

Removal of vancomycin administered during dialysis by a high-flux dialyzer.

Nyman HA, Agarwal A, Senekjian HO, Leypoldt JK, Cheung AK.

Hemodial Int. 2018 Jul;22(3):383-387. doi: 10.1111/hdi.12637. Epub 2018 Jan 30.

PMID:
29380499
6.

A Pseudo-One Compartment Model of Phosphorus Kinetics During Hemodialysis: Further Supporting Evidence.

Leypoldt JK, Agar BU, Cheung AK, Bernardo AA.

Artif Organs. 2017 Nov;41(11):1043-1048. doi: 10.1111/aor.12897. Epub 2017 May 26.

PMID:
29148130
7.

Kinetic Modeling of Incremental Ambulatory Peritoneal Dialysis Exchanges.

Guest S, Leypoldt JK, Cassin M, Schreiber M.

Perit Dial Int. 2017 Mar-Apr;37(2):205-211. doi: 10.3747/pdi.2016.00055. Epub 2017 Jan 17.

PMID:
28096442
8.

Effect of Treatment Duration and Frequency on Uremic Solute Kinetics, Clearances and Concentrations.

Leypoldt JK, Meijers BK.

Semin Dial. 2016 Nov;29(6):463-470. doi: 10.1111/sdi.12531. Epub 2016 Aug 31. Review.

PMID:
27578429
9.

Clinical safety and performance of VIVIA: a novel home hemodialysis system.

Bernardo AA, Marbury TC, McFarlane PA, Pauly RP, Amdahl M, Demers J, Hutchcraft AM, Leypoldt JK, Minkus M, Muller M, Stallard R, Culleton BF.

Nephrol Dial Transplant. 2017 Apr 1;32(4):685-692. doi: 10.1093/ndt/gfw044.

PMID:
27190336
10.

Prescriptions of dialysate potassium concentration during short daily or long nocturnal (high dose) hemodialysis.

Leypoldt JK, Agar BU, Bernardo AA, Culleton BF.

Hemodial Int. 2016 Apr;20(2):218-25. doi: 10.1111/hdi.12331. Epub 2015 Jul 14.

PMID:
26179136
11.

Pharmacokinetic assessment in patients receiving continuous RRT: perspectives from the Kidney Health Initiative.

Nolin TD, Aronoff GR, Fissell WH, Jain L, Madabushi R, Reynolds K, Zhang L, Huang SM, Mehrotra R, Flessner MF, Leypoldt JK, Witcher JW, Zineh I, Archdeacon P, Roy-Chaudhury P, Goldstein SL; Kidney Health Initiative.

Clin J Am Soc Nephrol. 2015 Jan 7;10(1):159-64. doi: 10.2215/CJN.05630614. Epub 2014 Sep 4.

12.

Potassium kinetics during hemodialysis.

Agar BU, Culleton BF, Fluck R, Leypoldt JK.

Hemodial Int. 2015 Jan;19(1):23-32. doi: 10.1111/hdi.12195. Epub 2014 Aug 5.

PMID:
25091596
13.

Low-Polydispersity Glucose Polymers as Osmotic Agents for Peritoneal Dialysis.

Leypoldt JK, Hoff CM, Akonur A, Holmes CJ.

Perit Dial Int. 2015 Jul-Aug;35(4):428-35. doi: 10.3747/pdi.2013.00232. Epub 2014 Mar 1.

14.

Predicting the Peritoneal Absorption of Icodextrin in Rats and Humans Including the Effect of α-Amylase Activity in Dialysate.

Akonur A, Holmes CJ, Leypoldt JK.

Perit Dial Int. 2015 May-Jun;35(3):288-96. doi: 10.3747/pdi.2012.00247. Epub 2014 Mar 1.

15.

Simplified phosphorus kinetic modeling: predicting changes in predialysis serum phosphorus concentration after altering the hemodialysis prescription.

Leypoldt JK, Agar BU, Culleton BF.

Nephrol Dial Transplant. 2014 Jul;29(7):1423-9. doi: 10.1093/ndt/gfu032. Epub 2014 Feb 24.

PMID:
24569497
16.
17.

Peritoneal residual volume induces variability of ultrafiltration with icodextrin.

Akonur A, Holmes CJ, Leypoldt JK.

Perit Dial Int. 2014 Jan-Feb;34(1):95-9. doi: 10.3747/pdi.2012.00175. Epub 2013 Oct 31.

18.

Determinants of phosphorus mobilization during hemodialysis.

Leypoldt JK, Agar BU, Akonur A, Hutchcraft AM, Story KO, Culleton BF.

Kidney Int. 2013 Oct;84(4):841-8. doi: 10.1038/ki.2013.205. Epub 2013 May 29.

19.

Phosphorus kinetics during hemodiafiltration: analysis using a pseudo-one-compartment model.

Leypoldt JK, Agar BU, Akonur A, Culleton BF.

Blood Purif. 2013;35 Suppl 1:59-63. doi: 10.1159/000346356. Epub 2013 Feb 25.

PMID:
23466381
20.

Clearance of middle molecules during haemodialysis and haemodiafiltration: new insights.

Leypoldt JK, Holmes CJ, Rutherford P.

Nephrol Dial Transplant. 2012 Dec;27(12):4245-7. doi: 10.1093/ndt/gfs475. No abstract available.

PMID:
23235952
21.

Ultrafiltration characteristics of glucose polymers with low polydispersity.

Leypoldt JK, Hoff CM, Piscopo D, Carr SN, Svatek JM, Holmes CJ.

Perit Dial Int. 2013 Mar-Apr;33(2):124-31. doi: 10.3747/pdi.2012.00009. Epub 2012 Nov 1.

22.

Physiologic volume of phosphorus during hemodialysis: predictions from a pseudo one-compartment model.

Leypoldt JK, Akonur A, Agar BU, Culleton BF.

Hemodial Int. 2012 Oct;16 Suppl 1:S15-9. doi: 10.1111/j.1542-4758.2012.00742.x.

PMID:
23036030
23.

Steady state phosphorus mass balance model during hemodialysis based on a pseudo one-compartment kinetic model.

Leypoldt JK, Agar BU, Akonur A, Gellens ME, Culleton BF.

Int J Artif Organs. 2012 Nov;35(11):969-80. doi: 10.5301/ijao.5000131.

PMID:
23065870
24.

Patient-specific phosphorus mobilization clearance during nocturnal and short daily hemodialysis.

Agar BU, Troidle L, Finkelstein FO, Kohn OF, Akonur A, Leypoldt JK.

Hemodial Int. 2012 Oct;16(4):491-6. doi: 10.1111/j.1542-4758.2012.00706.x. Epub 2012 May 11.

PMID:
22574966
25.

Improved equation for estimating single-pool Kt/V at higher dialysis frequencies.

Daugirdas JT, Leypoldt JK, Akonur A, Greene T, Depner TA; FHN Trial Group.

Nephrol Dial Transplant. 2013 Aug;28(8):2156-60. doi: 10.1093/ndt/gfs115. Epub 2012 May 4.

26.

A simple method to estimate phosphorus mobilization in hemodialysis using only predialytic and postdialytic blood samples.

Agar BU, Akonur A, Cheung AK, Leypoldt JK.

Hemodial Int. 2011 Oct;15 Suppl 1:S9-S14. doi: 10.1111/j.1542-4758.2011.00596.x.

PMID:
22093606
27.

Intermittent peritoneal dialysis: urea kinetic modeling and implications of residual kidney function.

Guest S, Akonur A, Ghaffari A, Sloand J, Leypoldt JK.

Perit Dial Int. 2012 Mar-Apr;32(2):142-8. doi: 10.3747/pdi.2011.00027. Epub 2011 Dec 1.

28.

Effect of hemodialysis and hemofiltration on plasma C.E.R.A. concentrations.

Leypoldt JK, Loghman-Adham M, Jordan P, Reigner B.

Hemodial Int. 2012 Jan;16(1):20-30. doi: 10.1111/j.1542-4758.2011.00634.x.

PMID:
22098670
29.

Kinetic model of phosphorus mobilization during and after short and conventional hemodialysis.

Agar BU, Akonur A, Lo YC, Cheung AK, Leypoldt JK.

Clin J Am Soc Nephrol. 2011 Dec;6(12):2854-60. doi: 10.2215/CJN.03860411. Epub 2011 Oct 27.

30.

Three-pore model predictions of 24-hour automated peritoneal dialysis therapy using bimodal solutions.

Akonur A, Leypoldt JK.

Perit Dial Int. 2011 Sep-Oct;31(5):537-44. doi: 10.3747/pdi.2010.00169. Epub 2011 May 31.

PMID:
21632445
31.

Assessing creatinine clearance from modification of diet in renal disease study equations in the ADEMEX cohort: limitations and potential applications.

Sloand JA, Leypoldt JK, Culleton BF, Gellens ME, Paniagua R, Amato D, Vonesh EF.

Clin J Am Soc Nephrol. 2011 Mar;6(3):598-604. doi: 10.2215/CJN.04970610. Epub 2010 Dec 16.

32.

Enhanced solute removal with intermittent, in-center, 8-hour nocturnal hemodialysis.

Troidle L, Finkelstein F, Hotchkiss M, Leypoldt JK.

Hemodial Int. 2009 Oct;13(4):487-91. doi: 10.1111/j.1542-4758.2009.00383.x.

PMID:
19840141
33.

Volume indicators and left ventricular mass during aggressive volume management in patients on thrice-weekly hemodialysis.

Goldfarb-Rumyantzev AS, Chelamcharla M, Bray BE, Leypoldt JK, Lavasani I, Nelson N, Lavasani T, Baird B, Cheung AK.

Nephron Clin Pract. 2009;113(4):c270-80. doi: 10.1159/000235252. Epub 2009 Aug 15.

PMID:
19684412
34.

A combined crystalloid and colloid pd solution as a glucose-sparing strategy for volume control in high-transport apd patients: a prospective multicenter study.

Freida P, Issad B, Dratwa M, Lobbedez T, Wu L, Leypoldt JK, Divino-Filho JC.

Perit Dial Int. 2009 Jul-Aug;29(4):433-42.

PMID:
19602609
35.

Ultrafiltration efficiency during automated peritoneal dialysis using glucose-based solutions.

Akonur A, Holmes CJ, Leypoldt JK.

Adv Perit Dial. 2008;24:69-74.

PMID:
18986005
36.

Scope and design of the Following Rehabilitation, Economics and Everyday-Dialysis Outcome Measurements (FREEDOM) Study.

Jaber BL, Finkelstein FO, Glickman JD, Hull AR, Kraus MA, Leypoldt JK, Liu J, Gilbertson D, McCarthy J, Miller BW, Moran J, Collins AJ; FREEDOM Study Group.

Am J Kidney Dis. 2009 Feb;53(2):310-20. doi: 10.1053/j.ajkd.2008.07.013. Epub 2008 Sep 27.

PMID:
18823688
37.

Association between serum 2-microglobulin level and infectious mortality in hemodialysis patients.

Cheung AK, Greene T, Leypoldt JK, Yan G, Allon M, Delmez J, Levey AS, Levin NW, Rocco MV, Schulman G, Eknoyan G; HEMO Study Group.

Clin J Am Soc Nephrol. 2008 Jan;3(1):69-77. Epub 2007 Dec 5.

38.

Acute peritonitis in a C57BL/6 mouse model of peritoneal dialysis.

Leypoldt JK, Kamerath CD, Gilson JF.

Adv Perit Dial. 2007;23:66-70.

PMID:
17886606
39.
40.

Cellular and morphological changes during neointimal hyperplasia development in a porcine arteriovenous graft model.

Li L, Terry CM, Blumenthal DK, Kuji T, Masaki T, Kwan BC, Zhuplatov I, Leypoldt JK, Cheung AK.

Nephrol Dial Transplant. 2007 Nov;22(11):3139-46. Epub 2007 Jun 30.

PMID:
17602194
41.

Elevated fibrinogen fragment levels in uremic plasma inhibit platelet function and expression of glycoprotein IIb-IIIa.

Thekkedath UR, Chirananthavat T, Leypoldt JK, Cheung AK, Mohammad SF.

Am J Hematol. 2006 Dec;81(12):915-26.

42.

Dialyzer clearances and mass transfer-area coefficients for small solutes at low dialysate flow rates.

Leypoldt JK, Kamerath CD, Gilson JF, Friederichs G.

ASAIO J. 2006 Jul-Aug;52(4):404-9.

PMID:
16883120
43.

Effects of anaesthesia on fluid and solute transport in a C57BL6 mouse model of peritoneal dialysis.

Shin SK, Kamerath CD, Gilson JF, Leypoldt JK.

Nephrol Dial Transplant. 2006 Oct;21(10):2874-80. Epub 2006 Jul 28.

PMID:
16877489
44.

The association of lipid levels with mortality in patients on chronic peritoneal dialysis.

Habib AN, Baird BC, Leypoldt JK, Cheung AK, Goldfarb-Rumyantzev AS.

Nephrol Dial Transplant. 2006 Oct;21(10):2881-92. Epub 2006 May 30.

PMID:
16735386
45.

Efficacy of local dipyridamole therapy in a porcine model of arteriovenous graft stenosis.

Kuji T, Masaki T, Goteti K, Li L, Zhuplatov S, Terry CM, Zhu W, Leypoldt JK, Rathi R, Blumenthal DK, Kern SE, Cheung AK.

Kidney Int. 2006 Jun;69(12):2179-85. Epub 2006 May 3.

46.

Perivascular tissue pharmacokinetics of dipyridamole.

Goteti K, Masaki T, Kuji T, Leypoldt JK, Cheung AK, Kern SE.

Pharm Res. 2006 Apr;23(4):718-28. Epub 2006 Mar 24.

PMID:
16552498
47.

Revisiting the hemodialysis dose.

Leypoldt JK, Cheung AK.

Semin Dial. 2006 Mar-Apr;19(2):96-101. Review.

PMID:
16551284
48.

Serum beta-2 microglobulin levels predict mortality in dialysis patients: results of the HEMO study.

Cheung AK, Rocco MV, Yan G, Leypoldt JK, Levin NW, Greene T, Agodoa L, Bailey J, Beck GJ, Clark W, Levey AS, Ornt DB, Schulman G, Schwab S, Teehan B, Eknoyan G.

J Am Soc Nephrol. 2006 Feb;17(2):546-55. Epub 2005 Dec 28.

49.
50.

A crossover study of short daily haemodialysis.

Goldfarb-Rumyantzev AS, Leypoldt JK, Nelson N, Kutner NG, Cheung AK.

Nephrol Dial Transplant. 2006 Jan;21(1):166-75. Epub 2005 Sep 16.

PMID:
16169869

Supplemental Content

Loading ...
Support Center